Harpagide alleviates neuroinflammation and cognitive dysfunction in sepsis-associated encephalopathy: Association with the MMP9/NF-κB signaling pathway
Harpagide lindert Neuroinflammation und kognitive Dysfunktion bei sepsisassoziierter Enzephalopathie: Zusammenhang mit dem MMP9/NF-κB-Signalweg
PLOS One · 05.11.2026 · 21 (11) · e0362296
DOI: 10.1371/journal.pone.0362296 ↗Auf einen Blick
In einem Mausmodell der sepsisassoziierten Enzephalopathie verbesserte Harpagide das Verhalten und verringerte neuroinflammatorische Veränderungen. Begleitend sanken MMP9 und phosphoryliertes NF-κB p65.
Fragestellung
Wirkt Harpagide im Mausmodell der sepsisassoziierten Enzephalopathie neuroprotektiv und über welche Signalwege?
Methode
Mausmodell der SAE durch intraperitoneale LPS-Gabe (18 mg/kg); Beurteilung von Verhalten, Histopathologie, Zytokinen, Netzwerkpharmakologie, Docking, Molekulardynamik und Western Blot.
Ergebnisse
Harpagide verbesserte die Verhaltensleistung, minderte pathologische Hirnveränderungen, erhielt Hippocampus-Neuronen und senkte TNF-α, IL-1β und IL-6. MMP9 und phosphoryliertes NF-κB p65 waren reduziert.
Schlussfolgerung der Autor:innen
Die Studie zeigt, dass Harpagide bei SAE neuroprotektiv wirkt und mit gedämpfter Neuroinflammation sowie verminderter MMP9/NF-κB-Signalisierung assoziiert ist.
Kernaussagen
- Harpagide verbesserte Verhalten im SAE-Mausmodell
- TNF-α, IL-1β und IL-6 waren unter Harpagide reduziert
- MMP9 und phosphoryliertes NF-κB p65 nahmen ab
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Fen Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Pyrans, NF-kappa B, Matrix Metalloproteinase 9, Sepsis-Associated Encephalopathy. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis-associated encephalopathy (SAE) is a severe neurological complication of sepsis, characterized by uncontrolled neuroinflammation and cognitive decline, yet no specific therapy is currently available. Harpagide, a naturally occurring iridoid glycoside, has been reported to possess anti-inflammatory and neuroprotective activities; however, its therapeutic potential in SAE remains unexplored. This study aimed to investigate whether Harpagide exerts neuroprotective effects in SAE and to elucidate the underlying molecular mechanisms.
Methods
A mouse model of SAE was established by intraperitoneal injection of lipopolysaccharide (LPS, 18 mg/kg). Cognitive performance was assessed using behavioral assays. Brain tissue morphology and neuronal survival were evaluated through histopathological examination. Glial cell activation and the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) were measured. Network pharmacology was employed to predict potential targets, followed by molecular docking and molecular dynamics simulations to predict binding interactions with core targets. Western blotting was performed to determine the expression levels of key proteins involved in the MMP9/NF-κB signaling pathway.
Results
Treatment with Harpagide significantly improved behavioral performance, ameliorated brain pathological changes, preserved hippocampal neurons, suppressed glial activation, and reduced the levels of TNF-α, IL-1β, and IL-6 in SAE mice. Network pharmacology analysis predicted four core targets: GAPDH, CASP3, MMP9, and ICAM1. Molecular docking and molecular dynamics simulations suggested stable binding between Harpagide and MMP9. Western blot analysis further showed that Harpagide treatment was associated with reduced expression of MMP9 and phosphorylated NF-κB p65 in both hippocampal and cortical tissues.
Conclusions
The present study demonstrates that Harpagide exerts neuroprotective effects in SAE, which are associated with mitigated neuroinflammation and reduced MMP9/NF-κB signaling, supporting its potential as a promising therapeutic candidate for this devastating condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- The Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- Guizhou Provincial People's Hospital, Guiyang, China.
- Guizhou Medical University, Guiyang, China.
- Shanghai Children's Medical Center Guizhou Hospital, Guiyang, China.
ORCID-Profile: Bin Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lou, F., Deng, G., Chen, J., Jing, Y., Wang, A., Zhang, M., Zhang, Y., & Wang, B. (2026). Harpagide alleviates neuroinflammation and cognitive dysfunction in sepsis-associated encephalopathy: Association with the MMP9/NF-κB signaling pathway. PLOS One, 21(11), e0362296. https://doi.org/10.1371/journal.pone.0362296
Vancouver
Lou F, Deng G, Chen J, Jing Y, Wang A, Zhang M, et al. Harpagide alleviates neuroinflammation and cognitive dysfunction in sepsis-associated encephalopathy: Association with the MMP9/NF-κB signaling pathway. PLOS One. 2026;21(11):e0362296. doi:10.1371/journal.pone.0362296
BibTeX
@article{Lou2026,
author = {Lou, Fen and Deng, Guochun and Chen, Jiejuan and Jing, Yijiang and Wang, Ao and Zhang, Mazhong and Zhang, Yongping and Wang, Bin},
title = {Harpagide alleviates neuroinflammation and cognitive dysfunction in sepsis-associated encephalopathy: Association with the MMP9/NF-κB signaling pathway},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362296},
doi = {10.1371/journal.pone.0362296}
}
EUVIMED